Boston Scientific Corporation
NYSEBoston Scientific has spent the past two weeks being repriced lower — down 11% in a month and touching a fresh 52-week low — and the central question now is whether that rerating is a correction or the start of something more structural. The most striking data point from the past fortnight is not the stock price but the coordinated analyst response to it. Ten firms cut their price…
Snapshot as of 6 May 2026
Boston Scientific has spent the past two weeks being repriced lower — down 11% in a month and touching a fresh 52-week low — and the central question now is whether that rerating is a correction or the start of…
Boston Scientific heads into its April 30 Q2 guidance call with the Street still firmly in the bull camp — but with a month of price weakness and a wave of target cuts fresh in the market's memory. The stock closed at…
Why this matters: Three distinct ORTEX data signals have aligned on Boston Scientific within 48 hours — cost to borrow, short interest, and options sentiment. The convergence suggests a coordinated shift in trader…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BSX — free to start on ORTEX.
Sign up for free →Open BSX on ORTEX